City

Iowa City (1)

Condition

Metastatic Sarcoma (2)

Unresectable Sarcoma (2)

Locally Advanced Sarcoma (1)

Metastatic Leiomyosarcoma (1)

Metastatic Soft Tissue Sarcoma (1)

Sarcoma (1)

Soft Tissue Sarcoma (1)

Unresectable Leiomyosarcoma (1)

Unresectable Soft Tissue Sarcoma (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Mohammed M Milhem (1)

National Cancer Institute (NCI) (1)

Collaborator

Genentech, Inc. (1)

Intervention

bevacizumab, gemcitabine, docetaxel and valproic acid (1)

computed tomography (1)

magnetic resonance imaging (1)

pegylated liposomal doxorubicin hydrochloride (1)

peposertib (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

unresectable sarcoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance

Not yet recruiting

Metastatic Leiomyosarcoma
+5 more

Computed Tomography
+3 more

(no location specified)

Feb 2, 2023

Sarcoma, Soft Tissue Sarcoma, Locally Advanced Sarcoma Trial in Iowa City (Bevacizumab, Gemcitabine, Docetaxel and Valproic

Completed

Sarcoma
+4 more

Bevacizumab, Gemcitabine, Docetaxel and Valproic Acid

Iowa City, Iowa

University of Iowa Hospitals and Clinics

Aug 8, 2018